Page last updated: 2024-09-05

cyclo(glycylprolyl) and Hypoxia-Ischemia, Brain

cyclo(glycylprolyl) has been researched along with Hypoxia-Ischemia, Brain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brimble, M; Gluckman, P; Guan, J; Harris, P; Mathai, S; Wen, JY; Zhang, R	1

Other Studies

1 other study(ies) available for cyclo(glycylprolyl) and Hypoxia-Ischemia, Brain

Article	Year
Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats. Neuropharmacology, 2007, Volume: 53, Issue:6 Topics: Animals; Apoptosis; Astrocytes; Brain; Brain Injury, Chronic; Diketopiperazines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Hypoxia-Ischemia, Brain; Male; Motor Activity; Neuroprotective Agents; Peptides, Cyclic; Rats; Rats, Wistar; Time Factors; Treatment Outcome	2007

Article

Year

Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats.

Neuropharmacology, 2007, Volume: 53, Issue:6

Topics: Animals; Apoptosis; Astrocytes; Brain; Brain Injury, Chronic; Diketopiperazines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Hypoxia-Ischemia, Brain; Male; Motor Activity; Neuroprotective Agents; Peptides, Cyclic; Rats; Rats, Wistar; Time Factors; Treatment Outcome

2007